Interventional Oncology Market to Reach $2.9 billion by 2024
The growth
of interventional oncology market is primarily driven by the rising
preference for minimally invasive procedures, expansion of the target patient
population, increasing public-private funding and government support for cancer
research, technological advancements in the field of interventional oncology,
and increasing government investments and funding for interventional oncology
and related...
Interventional Oncology Market to Reach $2.9 billion by 2024 | Emerging Economies Offer High Growth Potential
According to
the new market research report “Interventional Oncology
Market by Product (Radiofrequency, microwave, cryoablation, embolization,
guidewires), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE,
TAE), Cancer (Liver, Lung, Kidney, Bone Metastasis) – Global Forecast to 2024“,
published by MarketsandMarkets™, the Interventional Oncology Market is
projected...
Interventional Oncology Market | Growth, Trends and Forecast (2019-2024)
The interventional oncology market is projected to reach USD 2.9 billion by 2024 from USD 2.0 billion in 2019. The market is expected to grow at a CAGR of 6.8% from 2019 to 2024. The growth of this market is primarily driven by the rising preference for minimally invasive procedures, expansion of the target patient population, increasing public-private funding and government support for cancer research,...
Rising Opportunities in the Emerging Markets to Boost the Growth of the Interventional Oncology Market
The Global Interventional Oncology Market is anticipated to grow at a steady rate during the forecast period. The growth of the market is expected to be driven by major factors such as increasing acceptance and demand for minimally invasive cancer surgeries, technological advancements in the field of interventional oncology, and increasing prevalence of cancer cases across the globe.
Moreover, ongoing...